Targets miRBase

  1. Dashboard
  2. Targets

hsa-miR-145-5p (MIMAT0000437) (198 targets) in miRTarBase

miRNA gene name experiments
hsa-miR-145-5p BNIP3
qRT-PCR [1] [2]
microarray [2]
Western blot [1]
Luciferase reporter assay [1]
hsa-miR-145-5p KLF5
qRT-PCR [3] [4]
Western blot [3] [4]
Luciferase reporter assay [3]
hsa-miR-145-5p SOX2
qRT-PCR [5] [6]
In situ hybridization [5]
GFP reporter assay [5]
Reporter assay [5]
Western blot [5]
Other [5]
Luciferase reporter assay [5] [7]
Flow cytometry [5]
FACS [5]
hsa-miR-145-5p KLF4
qRT-PCR [4] [5] [6]
In situ hybridization [5]
GFP reporter assay [5]
Reporter assay [5]
Western blot [4] [5]
Luciferase reporter assay [5]
Flow cytometry [5]
FACS [5]
hsa-miR-145-5p MUC1
qRT-PCR [8]
Reporter assay [8]
Western blot [8] [9]
Luciferase reporter assay [8] [9] [10]
Immunohistochemistry [8]
hsa-miR-145-5p MYO6
qRT-PCR [11]
Western blot [11]
Luciferase reporter assay [11]
hsa-miR-145-5p STAT1
qRT-PCR [12]
microarray [12]
Western blot [12]
Luciferase reporter assay [12]
hsa-miR-145-5p YES1
qRT-PCR [12]
microarray [12] [13]
Reporter assay [13]
Western blot [12]
Luciferase reporter assay [12]
hsa-miR-145-5p PPP3CA
qRT-PCR [14]
microarray [14]
Reporter assay [14]
Other [14]
Luciferase reporter assay [14]
hsa-miR-145-5p CLINT1
qRT-PCR [14]
microarray [14]
Reporter assay [14]
Other [14]
Luciferase reporter assay [14]
hsa-miR-145-5p EGFR
qRT-PCR [15]
microarray [15]
Western blot [15]
hsa-miR-145-5p MAP3K3
microarray [16]
hsa-miR-145-5p MYC
qRT-PCR [17] [18] [19]
Western blot [17] [18] [19]
Luciferase reporter assay [17] [18]
hsa-miR-145-5p FLI1
Northern blot [20]
qRT-PCR [21] [20]
Western blot [21] [20] [22]
Luciferase reporter assay [21] [20] [22]
hsa-miR-145-5p IFNB1
qRT-PCR [23]
Luciferase reporter assay [23]
ELISA [23]
hsa-miR-145-5p TIRAP
Western blot [24]
Immunoprecipitaion [24]
Co-IP [24]
hsa-miR-145-5p POU5F1
qRT-PCR [25] [26] [27] [5]
In situ hybridization [5]
GFP reporter assay [5]
Reporter assay [5]
Immunofluorescence [26]
Western blot [28] [5] [29] [27]
Immunoblot [25] [27]
Luciferase reporter assay [7] [30] [25] [27] [5] [28]
Flow cytometry [25] [5]
Immunohistochemistry [25] [29]
FACS [5]
hsa-miR-145-5p IGF1R
qRT-PCR [31] [32]
Western blot [33] [32]
Luciferase reporter assay [33] [31]
hsa-miR-145-5p ROBO2
qRT-PCR [34]
In situ hybridization [34]
Reporter assay [34]
Western blot [34]
Luciferase reporter assay [34]
hsa-miR-145-5p SRGAP1
qRT-PCR [34] [2]
microarray [2]
In situ hybridization [34]
Western blot [34]
Luciferase reporter assay [34]
hsa-miR-145-5p EIF4E
qRT-PCR [18]
Western blot [18]
Luciferase reporter assay [18]
hsa-miR-145-5p CDK4
qRT-PCR [18]
Western blot [18]
Luciferase reporter assay [18]
hsa-miR-145-5p VEGFA
Northern blot [35]
qRT-PCR [36] [35] [37]
Western blot [36] [37]
Immunoblot [35]
Luciferase reporter assay [35] [37] [36]
Immunohistochemistry [35]
hsa-miR-145-5p SERPINE1
qRT-PCR [6] [38]
Western blot [38]
Immunoblot [38]
Luciferase reporter assay [38]
hsa-miR-145-5p IRS2
Luciferase reporter assay [39]
hsa-miR-145-5p ITGB8
qRT-PCR [40]
microarray [40]
In situ hybridization [40]
GFP reporter assay [40]
Immunofluorescence [40]
Western blot [40]
Luciferase reporter assay [40]
hsa-miR-145-5p SWAP70
qRT-PCR [41]
microarray [13]
Reporter assay [13] [41]
Western blot [41]
Luciferase reporter assay [41]
hsa-miR-145-5p ESR1
Luciferase reporter assay [42]
hsa-miR-145-5p NUDT1
qRT-PCR [15]
microarray [15]
Western blot [15]
hsa-miR-145-5p NEDD9
qRT-PCR [43] [44]
Immunofluorescence [43]
Western blot [43]
Luciferase reporter assay [45] [44]
Immunohistochemistry [43]
hsa-miR-145-5p PAK4
qRT-PCR [46]
Western blot [46]
Luciferase reporter assay [46]
hsa-miR-145-5p DDX17
Northern blot [47]
qRT-PCR [47]
Western blot [47]
Luciferase reporter assay [47]
hsa-miR-145-5p ERG
Luciferase reporter assay [48]
hsa-miR-145-5p NRAS
Northern blot [35]
qRT-PCR [35]
Western blot [49]
Immunoblot [35]
Luciferase reporter assay [49] [35]
Immunohistochemistry [35]
hsa-miR-145-5p ILK
qRT-PCR [50]
Western blot [50]
Luciferase reporter assay [50]
hsa-miR-145-5p CTGF
Luciferase reporter assay [51]
hsa-miR-145-5p SOCS7
Luciferase reporter assay [52]
hsa-miR-145-5p MDM2
Luciferase reporter assay [53]
hsa-miR-145-5p ADAM17
qRT-PCR [54]
Western blot [54]
HITS-CLIP [55]
Luciferase reporter assay [56] [54]
Immunohistochemistry [57]
hsa-miR-145-5p CDH2
microarray [16]
Western blot [58]
Luciferase reporter assay [58]
hsa-miR-145-5p HDAC2
Luciferase reporter assay [59]
hsa-miR-145-5p RTKN
qRT-PCR [60]
Reporter assay [60]
Western blot [60]
Other [60]
hsa-miR-145-5p F11R
qRT-PCR [6]
microarray [13]
Reporter assay [13] [61]
hsa-miR-145-5p ARL6IP5
microarray [13]
Reporter assay [13]
hsa-miR-145-5p AKR1B10
microarray [13]
Reporter assay [13]
hsa-miR-145-5p C11orf65
microarray [13]
Reporter assay [13]
hsa-miR-145-5p HLTF
microarray [13]
Reporter assay [13]
hsa-miR-145-5p GMFB
microarray [13]
Reporter assay [13]
hsa-miR-145-5p SERINC5
microarray [13]
Reporter assay [13]
hsa-miR-145-5p MEST
microarray [13]
Reporter assay [13]
hsa-miR-145-5p ALPPL2
microarray [13]
Reporter assay [13]
hsa-miR-145-5p NDRG2
microarray [13]
Reporter assay [13]
hsa-miR-145-5p DTD1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p TPM3
microarray [13]
Reporter assay [13]
PAR-CLIP [62]
hsa-miR-145-5p MAP2K6
microarray [13]
Reporter assay [13]
hsa-miR-145-5p CEP19
microarray [13]
Reporter assay [13]
hsa-miR-145-5p TPRG1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p GOLM1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p CCDC43
microarray [13]
Reporter assay [13]
hsa-miR-145-5p MMP1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p PTP4A2
microarray [13]
Reporter assay [13]
hsa-miR-145-5p TMEM9B
microarray [13]
Reporter assay [13]
hsa-miR-145-5p MMP12
microarray [13]
Reporter assay [13]
hsa-miR-145-5p MTMR14
microarray [13]
Reporter assay [13]
hsa-miR-145-5p ALDH3A1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p NDUFA4
microarray [13]
Reporter assay [13]
hsa-miR-145-5p FAM3C
microarray [13]
Reporter assay [13]
hsa-miR-145-5p LYPLA2
microarray [13]
Reporter assay [13]
hsa-miR-145-5p FAM45A
microarray [13]
Reporter assay [13]
hsa-miR-145-5p PIGF
microarray [13]
Reporter assay [13]
hsa-miR-145-5p AP1G1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p JADE1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p NIPSNAP1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p KREMEN1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p MMP14
microarray [13]
Reporter assay [13]
hsa-miR-145-5p ABRACL
microarray [13]
Reporter assay [13]
hsa-miR-145-5p MIXL1
microarray [13]
Reporter assay [13]
hsa-miR-145-5p TSPAN6
qRT-PCR [2]
microarray [13] [2]
Reporter assay [13]
hsa-miR-145-5p PODXL
qRT-PCR [6]
microarray [13]
Reporter assay [13]
HITS-CLIP [63]
hsa-miR-145-5p APH1A
microarray [13]
Reporter assay [13]
hsa-miR-145-5p ABHD17C
microarray [13]
Reporter assay [13]
hsa-miR-145-5p NANOG
Luciferase reporter assay [7]
hsa-miR-145-5p MYO5A
Luciferase reporter assay [64]
hsa-miR-145-5p EPAS1
qRT-PCR [65]
Western blot [65]
Luciferase reporter assay [65]
hsa-miR-145-5p ETS1
qRT-PCR [66]
Western blot [66]
Luciferase reporter assay [66]
Immunohistochemistry [66]
hsa-miR-145-5p RREB1
qRT-PCR [67]
Western blot [67]
Luciferase reporter assay [67]
Immunohistochemistry [67]
hsa-miR-145-5p COL5A1
qRT-PCR [68]
microarray [68]
Western blot [68]
Immunohistochemistry [68]
hsa-miR-145-5p CD44
qRT-PCR [3]
Western blot [3]
Luciferase reporter assay [3]
hsa-miR-145-5p BRAF
qRT-PCR [3]
Western blot [3]
Luciferase reporter assay [3]
hsa-miR-145-5p SOX9
qRT-PCR [69]
microarray [16]
Western blot [69]
Luciferase reporter assay [69]
Flow cytometry [69]
Immunohistochemistry [57]
hsa-miR-145-5p SOX11
microarray [16]
hsa-miR-145-5p SMAD3
qRT-PCR [70]
microarray [16]
Immunofluorescence [70]
Western blot [70]
Luciferase reporter assay [70] [71]
ELISA [70]
hsa-miR-145-5p SMAD5
microarray [16]
hsa-miR-145-5p TGFBR2
qRT-PCR [72]
microarray [16]
Western blot [72]
Luciferase reporter assay [72]
hsa-miR-145-5p SMAD4
microarray [16]
hsa-miR-145-5p MAP2K4
microarray [16]
hsa-miR-145-5p PDGFD
microarray [16]
hsa-miR-145-5p CTNND1
qRT-PCR [73]
microarray [16]
Western blot [73]
Luciferase reporter assay [73]
Immunohistochemistry [73]
hsa-miR-145-5p P4HA1
microarray [16]
hsa-miR-145-5p MAP4K2
microarray [16]
hsa-miR-145-5p MAP3K11
microarray [16]
hsa-miR-145-5p ERBB4
microarray [16]
hsa-miR-145-5p SP1
qRT-PCR [74]
Immunofluorescence [75]
Western blot [75] [74]
Luciferase reporter assay [75] [74]
Immunohistochemistry [74]
hsa-miR-145-5p TNFSF13
qRT-PCR [76]
Western blot [76]
Luciferase reporter assay [76]
Immunohistochemistry [76]
hsa-miR-145-5p CDK6
qRT-PCR [74] [77]
ChIP [77]
Western blot [77] [74]
HITS-CLIP [63]
Luciferase reporter assay [74] [77]
Immunohistochemistry [74] [77]
hsa-miR-145-5p ZFYVE9
PAR-CLIP [78]
hsa-miR-145-5p NUFIP2
PAR-CLIP [78]
hsa-miR-145-5p DDX6
qRT-PCR [79]
Immunofluorescence [79]
Western blot [79]
Luciferase reporter assay [79]
hsa-miR-145-5p HIST1H2AH
PAR-CLIP [62]
hsa-miR-145-5p ARF6
PAR-CLIP [80]
hsa-miR-145-5p PLAGL2
PAR-CLIP [78]
hsa-miR-145-5p NR1D2
PAR-CLIP [78]
hsa-miR-145-5p ADD3
qRT-PCR [69]
Western blot [69]
Luciferase reporter assay [69]
Flow cytometry [69]
hsa-miR-145-5p PADI1
qRT-PCR [2]
microarray [2]
hsa-miR-145-5p PHACTR2
qRT-PCR [2]
microarray [2]
hsa-miR-145-5p SNX24
qRT-PCR [2]
microarray [2]
hsa-miR-145-5p KIF21A
qRT-PCR [2]
microarray [2]
hsa-miR-145-5p SAMD5
qRT-PCR [2]
microarray [2]
hsa-miR-145-5p CRYBG1
qRT-PCR [2]
microarray [2]
hsa-miR-145-5p HMGA2
qRT-PCR [81]
microarray [81]
Western blot [81]
Luciferase reporter assay [81]
Immunohistochemistry [81]
hsa-miR-145-5p DDC
qRT-PCR [82]
Western blot [82]
hsa-miR-145-5p ANGPT2
qRT-PCR [44]
Luciferase reporter assay [44]
hsa-miR-145-5p ROCK1
Western blot [83]
Luciferase reporter assay [83]
hsa-miR-145-5p E2F3
qRT-PCR [77]
ChIP [77]
Western blot [77]
Luciferase reporter assay [77]
Immunohistochemistry [77]
hsa-miR-145-5p RPS6KB1
Luciferase reporter assay [10]
hsa-miR-145-5p CD28
Luciferase reporter assay [84]
hsa-miR-145-5p NFATC1
Luciferase reporter assay [84]
hsa-miR-145-5p SP7
qRT-PCR [85]
Western blot [85]
Luciferase reporter assay [85]
hsa-miR-145-5p HDAC11
qRT-PCR [86]
Western blot [86]
Luciferase reporter assay [86]
hsa-miR-145-5p CFTR
qRT-PCR [87]
Luciferase reporter assay [87]
hsa-miR-145-5p CSRNP3
PAR-CLIP [88]
hsa-miR-145-5p AAED1
PAR-CLIP [78]
hsa-miR-145-5p ZNF426
PAR-CLIP [78]
hsa-miR-145-5p UBR7
PAR-CLIP [78]
hsa-miR-145-5p SNTB1
PAR-CLIP [89] [78]
hsa-miR-145-5p SESN2
PAR-CLIP [78]
hsa-miR-145-5p REL
PAR-CLIP [78]
hsa-miR-145-5p PSAT1
PAR-CLIP [78] [62] [90]
hsa-miR-145-5p FZD6
PAR-CLIP [78]
hsa-miR-145-5p VGLL4
PAR-CLIP [91] [78]
hsa-miR-145-5p IVNS1ABP
PAR-CLIP [78]
hsa-miR-145-5p DNAJC28
PAR-CLIP [80]
hsa-miR-145-5p SLC16A10
PAR-CLIP [80]
hsa-miR-145-5p RPS6KA3
PAR-CLIP [80]
hsa-miR-145-5p EID2B
PAR-CLIP [62]
hsa-miR-145-5p DEK
PAR-CLIP [62]
hsa-miR-145-5p PRDM2
PAR-CLIP [90] [62]
hsa-miR-145-5p AGPS
HITS-CLIP [63]
PAR-CLIP [62]
hsa-miR-145-5p ZNF772
PAR-CLIP [62] [90]
hsa-miR-145-5p CYP2C19
PAR-CLIP [90] [91]
hsa-miR-145-5p ZNF100
PAR-CLIP [91]
hsa-miR-145-5p ZNF678
PAR-CLIP [91]
hsa-miR-145-5p CCDC80
PAR-CLIP [91]
hsa-miR-145-5p BTG1
PAR-CLIP [91]
hsa-miR-145-5p ANKRD28
PAR-CLIP [91]
hsa-miR-145-5p ZFAND3
PAR-CLIP [89]
hsa-miR-145-5p UBXN2A
PAR-CLIP [89]
hsa-miR-145-5p NUP43
PAR-CLIP [89]
hsa-miR-145-5p LMNB2
PAR-CLIP [90] [89]
hsa-miR-145-5p UTP15
PAR-CLIP [90]
hsa-miR-145-5p IGFBP5
PAR-CLIP [90]
hsa-miR-145-5p DUSP6
HITS-CLIP [55]
hsa-miR-145-5p C1orf27
HITS-CLIP [55]
hsa-miR-145-5p ALG9
HITS-CLIP [55]
hsa-miR-145-5p AGTRAP
HITS-CLIP [55]
hsa-miR-145-5p TNR
HITS-CLIP [55]
hsa-miR-145-5p SRPX2
HITS-CLIP [55]
hsa-miR-145-5p SLC22A9
HITS-CLIP [55]
hsa-miR-145-5p RRAGC
HITS-CLIP [55]
hsa-miR-145-5p WSB1
HITS-CLIP [55]
hsa-miR-145-5p RAB3IP
HITS-CLIP [55]
hsa-miR-145-5p ZNF445
HITS-CLIP [55]
hsa-miR-145-5p PANK1
HITS-CLIP [55]
hsa-miR-145-5p AQR
HITS-CLIP [55]
hsa-miR-145-5p IMMP2L
HITS-CLIP [55]
hsa-miR-145-5p SMIM17
HITS-CLIP [55]
hsa-miR-145-5p NDUFS2
HITS-CLIP [55]
hsa-miR-145-5p MUC4
HITS-CLIP [55]
hsa-miR-145-5p ZNF660
HITS-CLIP [55]
hsa-miR-145-5p UNC5D
HITS-CLIP [55]
hsa-miR-145-5p THSD7A
HITS-CLIP [55]
hsa-miR-145-5p SLC26A2
HITS-CLIP [55]
hsa-miR-145-5p ORC4
HITS-CLIP [55]
hsa-miR-145-5p HBEGF
HITS-CLIP [55]
hsa-miR-145-5p CXorf23
HITS-CLIP [55]
hsa-miR-145-5p CTNNBIP1
HITS-CLIP [55]
hsa-miR-145-5p CLSTN2
HITS-CLIP [55]
hsa-miR-145-5p ZNF451
HITS-CLIP [63]
hsa-miR-145-5p ZBTB25
HITS-CLIP [63]
hsa-miR-145-5p CCDC85C
HITS-CLIP [63]
hsa-miR-145-5p MAP1LC3B
HITS-CLIP [63]
hsa-miR-145-5p ABCC1
HITS-CLIP [63]
hsa-miR-145-5p TGFBI
HITS-CLIP [92]
hsa-miR-145-5p RBM18
HITS-CLIP [92]
hsa-miR-145-5p SLC16A5
HITS-CLIP [92]
hsa-miR-145-5p MUC19
HITS-CLIP [92]
hsa-miR-145-5p PNMA3
HITS-CLIP [92]
hsa-miR-145-5p CRAMP1
HITS-CLIP [92]

References

authors journal year Pubmed link title
1 Chen et al. Cancer Res. 2010 20332243 MicroRNA145 targets BNIP3 and suppresses prostate cancer progression.
2 Lu et al. PLoS ONE 2012 22815788 MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets.
3 Pagliuca et al. Oncogene 2013 23128394 Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression.
4 Dahan et al. Am. J. Physiol., Cell Physiol. 2014 25273883 Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility.
5 Xu et al. Cell 2009 19409607 MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
6 Adammek et al. Fertil. Steril. 2013 23312222 MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors.
7 Wang et al. Dev. Cell 2013 23541921 Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.
8 Sachdeva et al. Cancer Res. 2010 19996288 MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1.
9 Sachdeva et al. Am J Transl Res 2010 20407606 miR-145-mediated suppression of cell growth, invasion and metastasis.
10 Wu et al. Biochem. Biophys. Res. Commun. 2013 24157791 MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
11 Szczyrba et al. Mol. Cancer Res. 2010 20353999 The microRNA profile of prostate carcinoma obtained by deep sequencing.
12 Gregersen et al. PLoS ONE 2010 20098684 MicroRNA-145 targets YES and STAT1 in colon cancer cells.
13 Kano et al. Int. J. Cancer 2010 21351259 miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
14 Ostenfeld et al. Oncogene 2010 19915607 miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.
15 Cho et al. RNA Biol 2011 21289483 MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.
16 Bakhshandeh et al. J. Genet. 2012 22942087 A microRNA signature associated with chondrogenic lineage commitment.
17 Sachdeva et al. Proc. Natl. Acad. Sci. U.S.A. 2009 19202062 p53 represses c-Myc through induction of the tumor suppressor miR-145.
18 Chen et al. J. Exp. Clin. Cancer Res. 2010 21092188 miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
19 Shao et al. Cancer Cell Int. 2013 23710609 MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.
20 Zhang et al. Cancer 2011 20737575 Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
21 Riggi et al. Genes Dev. 2010 20382729 EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells.
22 Ban et al. Oncogene 2011 21217773 Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
23 Witwer et al. J. Immunol. 2010 20130213 MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response.
24 Starczynowski et al. Nat. Med. 2010 19898489 Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.
25 Cioce et al. Oncogene 2014 24240684 Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.
26 Chinnathambi et al. J. Dermatol. 2012 22486352 Treatment with the cancer drugs decitabine and doxorubicin induces human skin keratinocytes to express Oct4 and the OCT4 regulator mir-145.
27 Hu et al. PLoS ONE 2012 23049906 MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4.
28 Wang et al. Carcinogenesis 2013 23615404 Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.
29 Jia et al. Oncol. Rep. 2012 22378186 Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
30 Zhang et al. Zhongguo Fei Ai Za Zhi 2011 21496429 [miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
31 Farrokhnia et al. J. Biol. Chem. 2014 25077964 MicroRNA regulation of mitogenic signaling networks in the human placenta.
32 La Rocca et al. J. Cell. Physiol. 2009 19391107 Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway.
33 Zhu et al. FEBS Lett. 2014 24999188 MicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cells.
34 Zhang et al. Brain Res. 2011 21276775 MicroRNAs 144, 145, and 214 are down-regulated in primary neurons responding to sciatic nerve transection.
35 Zou et al. Cell Cycle 2012 22592534 MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.
36 Fan et al. Acta Biochim. Biophys. Sin. (Shanghai) 2012 22472569 MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells.
37 Wu et al. J Hematol Oncol 2014 24886719 Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.
38 Villadsen et al. Br. J. Cancer 2012 22108519 The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.
39 Law et al. Carcinogenesis 2012 22431718 MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
40 Lee et al. PLoS ONE 2011 21701675 MicroRNA-145 regulates human corneal epithelial differentiation.
41 Chiyomaru et al. Prostate 2011 21360565 SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.
42 Spizzo et al. Cell Death Differ. 2010 19730444 miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
43 Speranza et al. Oncotarget 2012 22869051 NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
44 Lu et al. J. Cancer Res. Clin. Oncol. 2014 24384875 miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
45 Guo et al. J. Cell. Biochem. 2013 23355420 HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
46 Wang et al. Biochem. Biophys. Res. Commun. 2012 22766504 MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells.
47 Takaoka et al. PLoS ONE 2012 22876303 Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
48 Hart et al. FEBS J. 2013 23480797 The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer.
49 Yin et al. Biochim. Biophys. Acta 2013 23201159 Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
50 Noguchi et al. Cancer Lett. 2013 23104321 Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
51 Lee et al. PLoS ONE 2013 23390502 MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
52 Noguchi et al. Cell Death Dis 2013 23392170 socs7, a target gene of microRNA-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells.
53 Zhang et al. Oncogene 2013 22330136 Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop.
54 Lu et al. Oncol. Rep. 2013 23076445 MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.
55 Karginov et al. Genes Dev. 2013 23824327 Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates.
56 Doberstein et al. Neoplasia 2013 23441135 MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients.
57 Yu et al. Cancer Res. 2013 23548270 miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
58 Gao et al. Oncogene 2013 22370644 The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer.
59 Noh et al. Cancer Lett. 2013 23499894 MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
60 Wang et al. Int. J. Oncol. 2009 19360360 miR-145 inhibits breast cancer cell growth through RTKN.
61 Götte et al. Oncogene 2010 20818426 miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
62 Memczak et al. Nature 2013 23446348 Circular RNAs are a large class of animal RNAs with regulatory potency.
63 Xue et al. Cell 2013 23313552 Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits.
64 Dynoodt et al. J. Invest. Dermatol. 2013 22895360 Identification of miR-145 as a key regulator of the pigmentary process.
65 Zhang et al. Oncogene 2014 23222716 MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
66 Zheng et al. Mol. Cancer Res. 2013 23233482 miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells.
67 Kent et al. Oncogene 2013 22751122 RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
68 Kliese et al. Oncogene 2013 23108408 miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
69 Rani et al. Neuro-oncology 2013 23814265 MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.
70 Yang et al. FEBS Lett. 2014 24873879 Effect of microRNA-145 on IL-1β-induced cartilage degradation in human chondrocytes.
71 Megiorni et al. J. Cyst. Fibros. 2013 23632450 Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients.
72 Yang et al. Biol. Reprod. 2013 23986572 Expression patterns and regulatory functions of microRNAs during the initiation of primordial follicle development in the neonatal mouse ovary.
73 Xing et al. J. Pathol. 2015 25470111 Catenin-δ1, negatively regulated by miR-145, promotes tumour aggressiveness in gastric cancer.
74 Zhu et al. Int. J. Cancer 2014 24510775 miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6.
75 Qiu et al. FEBS Lett. 2014 24613927 MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
76 Zhi et al. Cell. Physiol. Biochem. 2015 25612651 APRIL induces cisplatin resistance in gastric cancer cells via activation of the NF-κB pathway.
77 Chang et al. Oncotarget 2015 25762621 miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells.
78 Whisnant et al. MBio 2013 23592263 In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.
79 Iio et al. Biochim. Biophys. Acta 2013 23932921 DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
80 Skalsky et al. PLoS Pathog. 2012 22291592 The viral and cellular microRNA targetome in lymphoblastoid cell lines.
81 Kim et al. Cancer Lett. 2015 25444913 miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
82 Papadopoulos et al. Gene 2015 25445287 Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow.
83 Wan et al. Mol Med Rep 2014 24573110 ROCK1, a novel target of miR-145, promotes glioma cell invasion.
84 Wang et al. J Neuroimmune Pharmacol 2013 24043548 Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.
85 Jia et al. FEBS Lett. 2013 23886710 miR-145 suppresses osteogenic differentiation by targeting Sp7.
86 Lin et al. J. Immunol. 2013 23980205 Type I IFN inhibits innate IL-10 production in macrophages through histone deacetylase 11 by downregulating microRNA-145.
87 Oglesby et al. J. Immunol. 2013 23436935 Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
88 Gottwein et al. Cell Host Microbe 2011 22100165 Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.
89 Kishore et al. Nat. Methods 2011 21572407 A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins.
90 Hafner et al. Cell 2010 20371350 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.
91 Lipchina et al. Genes Dev. 2011 22012620 Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.
92 Chi et al. Nature 2009 19536157 Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps.
Imprint Data protection